Access
To read this story in full you will need to login or make a payment (see right).
news feature
Nature 417, 584-586 (6 June 2002) | doi:10.1038/417584a
Therapeutic antibodies: Magic bullets hit the target
Trisha Gura1
Top of page
Abstract
After decades of disappointment, antibodies are finally emerging as viable — if expensive — drugs. Trisha Gura finds biotech start-ups and pharmaceutical giants rushing to claim a piece of the action.
For more than a century, doctors have dreamt of using antibodies as 'magic bullets' to cure their patients. After all, these highly targeted proteins are among the immune system's key weapons.
To read this story in full you will need to login or make a payment (see right).
